Passage Bio Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$4.85

+0.15 (+3.19%)

As of Jun 29, 10:32 PM ET ·

Analyst Consensus

Buy

Analysts

Moderate

Coverage

Buy 7 64%

Hold 4 36%

Sell 0 0%

Price Target

Analyst Price Target +649.1% upside

Low Target $21.56

Average Target $36.33

High Target $42.60

Current Price $4.85

Current
$4.85

Target
$36.33

$21.56 $36.33 avg $42.60

Scenario Analysis

Bear Case

$21.56

344.5%

Low target

Base Case

$36.33

+649.1%

Avg target

Bull Case

$42.60

+778.4%

High target

Risk/Reward

2.3x

Favorable

Price in Context

52-Week High

$20.00

-75.8% from high

52-Week Low

$3.29

+47.4% from low

Target vs 52W High

$36.33

+81.7% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+2.4%
AMGN Amgen Inc	Hold	44	50%	$190.87	-47.3%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+187.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-11.8%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.7%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-66.0%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-39.1%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-47.4%